Investment Banking
CytRx Corp. announces agreement with Sands Brothers
Published in Gene Therapy Weekly, November 21st, 2002
CytRx's new relationship with Sands Brothers may provide CytRx with much needed sponsorship in the Nasdaq Small Cap arena. Sands Brothers and its affiliates employ a staff of over 500 professionals, with offices in New York, London, California, Florida, Texas, and Colorado.
CytRx Corporation is a biopharmaceutical company focused on the development and commercialization of high-value human...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2002-11-21)
More Articles from Gene Therapy Weekly
- Cancer Gene Therapy
Gene agent inhibits tumor growth through apoptosis - Urinary Disease
Ex vivo gene transfer may offer better option for treating urinary problems - Bladder Cancer
Low receptor levels impact adenovirus-based bladder cancer gene therapy - Colorectal Cancer
Cytokine gene therapy shows antitumor effect on small rectal cancers - Inflammatory Bowel Disease
Antisense oligonucleotides rebuff intestinal inflammation in ileitis model - Peripheral Vascular Disease
Growth factor beneficial for restoring vascular function in limbs - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
